Status of Ongoing Proceedings

For information on how to obtain public transcripts of proceedings, please contact the Registrar, Guillaume Couillard, by phone at 613-288-9635 or by e-mail at Guillaume.Couillard@pmprb-cepmb.gc.ca.

Dates of Upcoming Hearings or Pre-Hearing Conferences

blank
Case Event Date / Location
Procysbi - Horizon Therapeutics Canada Hearing TBD

Matters before the Board

I. Allegations of excessive pricing

Patented Medicine - Cysteamine bitartrate sold under the name Procysbi
Patentee Indication / Use Date of Notice of Hearing / Status
Horizon Therapeutics Canada Nephropathic cystinosis January 14, 2019

II. Failure to File

blank
Patented Drug Product Indication / Use Patentee Issue Date of Notice of Hearing / Status
blank blank Apotex Inc. Failure to file (jurisdiction) March 3, 2008

Judicial Review of Board Decisions and Appeals

blank
Patented Drug Product Indication / Use Patentee Issue Date of Notice of Hearing / Status
Soliris Paroxysmal Nocturnal Hemoglobinuria

Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals Inc. Allegations of excessive pricing

January 20, 2015

Court File T-1537-15

  • Notice of Appeal filed at Federal Court of Appeal: February 15, 2017 (A-51-17)
  • Federal Court reasons for Order dismissing applicant’s motion: January 6, 2017
    (2017 FC 22)
  • Federal Court Order dismissing applicant’s motion to appeal June 23, 2016 decision: December 28, 2016
  • Federal Court decision granting respondent’s motion to strike application: June 23, 2016 (2016 FC 716)
  • Application for judicial review filed at the Federal Court: September 11, 2015

Court File T-1855-15

  • Federal Court Order staying application: February 10, 2016
  • Application for judicial review filed at the Federal Court: November 3, 2015
  • Board Decision: October 5, 2015

Court File T-1160-16

  • Federal Court reasons for Order dismissing applicant’s motion: January 6, 2017 (2017 FC 21)
  • Federal Court Order dismissing applicant’s motion to appeal September 2, 2016 decision: December 28, 2016
  • Federal Court Order dismissing application: September 2, 2016
  • Application for judicial review filed at the Federal Court: July 13, 2016
  • Board Decision: June 10, 2016

Court File T-110-17

  • Application for judicial review filed at the Federal Court: January 23, 2017
Differin
Differin XP
Acne Galderma Canada Inc. Failure to file (jurisdiction)

February 23, 2016

Court File T-83-17

  • Application for judicial review filed at the Federal Court: January 18, 2017
Date modified: